Manuel Castro De Moura

6PUBLICATIONS
58CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

|Jul 14, 2025
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas.

Alberto J Arribas, Francesca Guidetti, Eleonora Cannas

|Dec 05, 2023
ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms.

Alberto J Arribas, Sara Napoli, Luciano Cascione

|Sep 28, 2021
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies.

Carlos A Garcia-Prieto, Lorea Villanueva, Alberto Bueno-Costa

|May 04, 2021
DDR1 methylation is associated with bipolar disorder and the isoform expression and methylation of myelin genes.

Beatriz Garcia-Ruiz, Manuel Castro de Moura, Gerard Muntané

|May 13, 2020
The DNA methylation landscape of human cancer organoids available at the American type culture collection.

Ricky Joshi, Manuel Castro De Moura, David Piñeyro

Pageof 1

Frequent Collaborators

6 joint publications

Manel Esteller

3 joint publications

Francesco Bertoni

3 joint publications

Giulio Sartori

3 joint publications

Emanuele Zucca